A Study of PF-08046052/SGN-EGFRd2 in Advanced Solid Tumors

Clinical trial NCT05983133 · TERMINATED

Trial details

NCT number: NCT05983133
Sponsor: Seagen, a wholly owned subsidiary of Pfizer
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Colorectal Neoplasms Carcinoma, Non-Small-Cell Lung Squamous Cell Carcinoma of the Head and Neck Pancreatic Ductal Adenocarcinoma

Start date: 2023-11-14
Primary completion: 2026-04-16
Enrollment: 68

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.